DNAAF3 and cystic fibrosis: Cystic fibrosis (CF) could be excluded by sweat tests, additionally, the PCD mutation panel (Blueprint genetics, Espoo, Finland) also covered frequent CFTR mutations (85% of all CF cases), making the existence of CF as a comorbidity very unlikely.